IRIS
ORIO, Francesco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 23.189
EU - Europa 11.375
AS - Asia 6.153
SA - Sud America 907
AF - Africa 79
Continente sconosciuto - Info sul continente non disponibili 64
OC - Oceania 25
Totale 41.792
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 23.065
RU - Federazione Russa 3.468
UA - Ucraina 2.805
VN - Vietnam 1.840
CN - Cina 1.825
SG - Singapore 1.779
GB - Regno Unito 1.203
SE - Svezia 1.115
DE - Germania 1.027
BR - Brasile 710
FR - Francia 599
IT - Italia 447
FI - Finlandia 342
KR - Corea 129
PL - Polonia 120
IN - India 102
HK - Hong Kong 81
BD - Bangladesh 71
EU - Europa 62
AR - Argentina 59
CA - Canada 59
IQ - Iraq 59
NL - Olanda 42
TR - Turchia 35
VE - Venezuela 35
JP - Giappone 34
CO - Colombia 31
SA - Arabia Saudita 29
BE - Belgio 28
MX - Messico 28
PK - Pakistan 27
EC - Ecuador 26
AT - Austria 24
LV - Lettonia 23
UZ - Uzbekistan 22
ZA - Sudafrica 21
AU - Australia 19
ES - Italia 19
IE - Irlanda 19
PH - Filippine 18
ID - Indonesia 16
MA - Marocco 15
TN - Tunisia 12
CL - Cile 11
DK - Danimarca 10
PE - Perù 10
PT - Portogallo 10
PY - Paraguay 10
BG - Bulgaria 8
BO - Bolivia 8
CZ - Repubblica Ceca 8
JO - Giordania 8
KE - Kenya 8
MY - Malesia 8
AZ - Azerbaigian 7
HU - Ungheria 7
IL - Israele 7
AE - Emirati Arabi Uniti 6
BY - Bielorussia 6
EG - Egitto 6
HR - Croazia 6
OM - Oman 6
PA - Panama 6
RS - Serbia 6
AL - Albania 5
BH - Bahrain 5
CR - Costa Rica 5
JM - Giamaica 5
LT - Lituania 5
NZ - Nuova Zelanda 5
PS - Palestinian Territory 5
KG - Kirghizistan 4
SY - Repubblica araba siriana 4
UY - Uruguay 4
DO - Repubblica Dominicana 3
ET - Etiopia 3
HT - Haiti 3
KW - Kuwait 3
LU - Lussemburgo 3
MM - Myanmar 3
NO - Norvegia 3
RO - Romania 3
TW - Taiwan 3
AO - Angola 2
BN - Brunei Darussalam 2
CY - Cipro 2
DZ - Algeria 2
EE - Estonia 2
GD - Grenada 2
GR - Grecia 2
HN - Honduras 2
IM - Isola di Man 2
IR - Iran 2
LB - Libano 2
ME - Montenegro 2
NG - Nigeria 2
NP - Nepal 2
SR - Suriname 2
TT - Trinidad e Tobago 2
XK - ???statistics.table.value.countryCode.XK??? 2
Totale 41.760
Salva come PNG Salva come JPEG
Città #
Fairfield 2.739
Woodbridge 2.587
Houston 1.975
Ashburn 1.686
Dong Ket 1.474
Ann Arbor 1.448
Chandler 1.364
Wilmington 1.312
Seattle 1.085
Dallas 1.009
Cambridge 933
San Jose 911
Dearborn 890
Jacksonville 777
Singapore 666
Southend 630
Nyköping 614
Boardman 475
Moscow 428
Beijing 378
Lawrence 258
Princeton 258
The Dalles 208
Ogden 178
Düsseldorf 137
Shanghai 127
Ho Chi Minh City 124
Des Moines 115
Kraków 108
Los Angeles 107
Hanoi 94
Yubileyny 90
San Diego 88
Helsinki 82
Bremen 75
Hong Kong 70
Grafing 66
Nanjing 62
New York 61
São Paulo 58
Santa Clara 56
Jinan 55
London 54
Chicago 41
Hefei 40
Frankfurt am Main 33
Tokyo 32
Edinburgh 28
Norwalk 28
Brussels 27
Shenyang 27
Amsterdam 26
Kunming 24
Munich 24
San Mateo 24
Baghdad 23
Da Nang 23
Riga 23
Guangzhou 22
Rome 22
Napoli 21
Nanchang 20
Council Bluffs 19
Rio de Janeiro 19
Tashkent 19
Auburn Hills 18
Belo Horizonte 18
Chennai 17
Hanover 17
Montreal 17
Phoenix 17
Zhengzhou 17
Mirabella Eclano 16
Taiyuan 16
Atlanta 15
Boston 15
Brooklyn 15
Hangzhou 15
Naples 15
Curitiba 14
Dublin 14
Kilburn 14
Vienna 14
Hebei 13
Riyadh 13
Tianjin 13
Changsha 12
Columbus 12
Falls Church 12
Saint Petersburg 12
Brasília 11
Caracas 11
Charlotte 11
Hounslow 11
Johannesburg 11
Porto Alegre 11
San Francisco 11
Stockholm 11
Acton 10
Campinas 10
Totale 26.956
Salva come PNG Salva come JPEG
Nome #
Il microinfusore: quali indicazioni e quando iniziare 469
Sussidio didattico per gli studenti di igiene generale e applicata per il corso di laurea in scienze del servizio sociale 331
Abnormal heart rate recovery after maximal cardiopulmonary exercise stress testing in young overweight women with polycystic ovary syndrome. 300
Berberine improves reproductive features in obese Caucasian women with polycystic ovary syndrome independently of changes of insulin sensitivity 270
The good and bad effects of statins on insulin sensitivity and secretion 251
Effects of physical exercise on the female reproductive system. 248
Adrenal adenoma and normal androgen levels in a young woman with polycystic ovaries: a case of idiopathic hirsutism? 247
High prevalence of endocrine dysfunction in long-term survivors after allogeneic bone marrow transplantation for hematologic diseases. 242
Secrezioni ormonali ectopiche 238
Cardiopulmonary impairment in young women with polycystic ovary syndrome. 237
A randomized controlled trial evaluating metformin pre-treatment and co-administration in non-obese insulin-resistant women with polycystic ovary syndrome treated with controlled ovarian stimulation plus timed intercourse or intrauterine insemination. 237
Gonadal status in reproductive age women after haematopoietic stem cell transplantation for haematological malignancies. 231
Abdominal fat quantity and distribution in women with polycystic ovary syndrome and extent of its relation to insulin resistance 228
Current Insights Into Inositol Isoforms, Mediterranean and Ketogenic Diets for Polycystic Ovary Syndrome: From Bench to Bedside. 225
A stable prostatic bioluminescent cell line to investigate androgen and antiandrogen effects. 222
The Risk of a Persistent Glucose Metabolism Impairment After Gestational Diabetes Mellitus Is Increased in Patients With Polycystic Ovary Syndrome 221
Cardiological aspects of growth hormone and insulin-like growth factor-I. 220
Endocrine secretions under abnormal light-dark cycles and in the blind. 216
Vitamin D and thyroid disease: to D or not to D? 213
Failure of long-term therapy with sodium valproate in Cushing's disease. 212
Adiponectin levels in women with polycystic ovary syndrome 212
Liver-spleen axis, Insulin-like Growth Factor-(IGF)-I axis and fat mass in overweight/obese females 211
Adrenal mass: insight into pathogenesis and a common link with insulin resistance. 210
Effectiveness of combined GnRH analogue plus raloxifene administration in the treatment of uterine leiomyomas: a prospective, randomized, single-blind, placebo-controlled clinical trial. 208
THE IMPACT OF PROBAND GLUCOSE TOLERANCE STATUS ON BODY MASS INDEX (BMI) AND ADIPOSITY IN ADOLESCENT GIRLS AT HIGH RISK FOR POLYCYSTIC OVARY SYNDROME (PCOS) 207
Early impairment of endothelial structure and function in young normal-weight women with polycystic ovary syndrome 207
The cardiovascular risk of young women with polycystic ovary syndrome: an observational, analytical, prospective case-control study 207
Height, weight, height velocity of primary school population sample in Campania region. 206
Effects of neridronate treatment in elderly women with osteoporosis 205
Ovulation induction in polycystic ovary syndrome 205
Gonadotropin-releasing hormone agonist with or without raloxifene: effects on cognition, mood and quality of life 203
Lifestyle changes in the management of adulthood and childhood obesity. 202
Low 25 (OH) vitamin D levels are associated with autoimmune thyroid disease in polycystic ovary syndrome 202
Bisphenol A in Polycystic Ovary Syndrome and its Association with Liver-Spleen Axis. 201
Systemic and local effects of metformin administration in patients with polycystic ovary syndrome (PCOS): relationship to the ovulatory response 201
Human prostatic cell line PNT1A, a useful tool for studying androgen receptor transcriptional activity and its differential subnuclear localization in the presence of androgens and antiandrogens. 200
Report on the Third Annual Meeting of the Androgen Excess Society, San Diego, California, June 3, 2005 199
Hypothalamic-pituitary-gonadal axis function after successful kidney transplantation in men and women 199
Visceral fat is associated with cardiovascular risk in women with polycystic ovary syndrome. 199
The impact of vitamin D deficiency on patients undergoing kidney transplantation: focus on cardiovascular, metabolic, and endocrine outcomes. 199
Effect of growth hormone on cardiac function. 198
Growth rate and growth hormone response to growth hormone-releasing hormone challenge in slowly growing children during chronic administration of clonidine. 198
The increase of leukocytes as a new putative marker of low- grade chronic inflammation and early cardiovascular risk in polycystic ovary syndrome 198
Adrenocortical tumors and insulin resistance. What is the first step? 197
Are serum adiponectin levels really reduced in obese women with polycystic ovary syndrome? 197
Growth hormone secretion after baclofen administration in different phases of menstrual cycle in healthy women. 196
Could the Mediterranean diet be effective in women with polycystic ovary syndrome? A proof of concept. 196
Metformin reduces risk of ovarian hyperstimulation syndrome in patients with polycystic ovary syndrome during gonadotropin-stimulated in vitro fertilization cycles: a randomized, controlled trial. 195
Early carotid atherosclerosis in normotensive severe obese premenopausal women with low DHEA(S). 195
Beneficial treatment with risedronate in long-term survivors after allogeneic stem cell transplantation for hematological malignancies. 194
Evidence-based and potential benefits of metformin in the polycystic ovary syndrome: a comprehensive review 194
Oral contraceptives versus physical exercise on cardiovascular and metabolic risk factors in women with polycystic ovary syndrome: a randomized controlled trial 194
Insulin resistance in postmenopausal women with metabolic syndrome and the measurements of adiponectin, leptin, resistin, and ghrelin 193
Exercise training improves autonomic function and inflammatory pattern in women with polycystic ovary syndrome 193
Visceral fat and cardiovascular risk in patients with polycystic ovary syndrome. 192
Raloxifene administration in women treated with gonadotropin-releasing hormone agonist for uterine leiomyomas: effects on bone metabolism. 192
Metformin administration and laparoscopic ovarian drilling improve ovarian response to clomiphene citrate (CC) in oligo-anovulatory CC-resistant women with polycystic ovary syndrome 192
How to manage the reproductive issues of PCOS: a 2015 integrated endocrinological and gynecological consensus statement of the Italian Society of Endocrinology. 192
Growth hormone secretion after baclofen administration in different phases of menstrual cycle in healthy women 191
Laparoscopic ovarian diathermy vs clomiphene citrate plus metformin as second-line strategy for infertile anovulatory patients with polycystic ovary syndrome: a randomized controlled trial 191
Auditory brainstem responses in thyroid diseases before and after therapy. 191
Is the ovulation induction still a therapeutic problem in patients with polycystic ovary syndrome? 191
Serum 25-Hydroxyvitamin D Levels, phosphoprotein enriched in diabetes gene product (PED/PEA-15) and leptin-to-adiponectin ratio in women with PCOS 191
Beneficial effects of a three-month structured exercise training program on cardiopulmonary functional capacity in young women with polycystic ovary syndrome. 191
Thyroid function and morphology after a successful kidney transplantation 190
Endothelial dysfunction in PCOS: role of obesity and adipose hormones. 190
Does raloxifene inhibit the growth of uterine fibroids? 189
Growth hormone status in morbidly obese subjects and correlation with body composition 189
Effect of estrogen replacement plus low-dose alendronate treatment on bone density in surgically postmenopausal women with osteoporosis. 189
Screening a coastal population in Southern Italy: iodine deficiency and prevalence of goitre, nutritional aspects and cardiovascular risk factors 189
Endocrinopathies after allogeneic and autologous transplantation of hematopoietic stem cells. 189
Terapia di associazione con insulina ed analoghi del GLP-1 188
Homocysteine levels and C677T polymorphism of methylenetetrahydrofolate reductase in women with polycystic ovary syndrome 188
Uterine effects of metformin administration in anovulatory women with polycystic ovary syndrome 187
Effect of preconceptional metformin on abortion risk in polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials 186
Current evidence on vitamin D deficiency and kidney transplant: What’s new? 186
Role of dehydroepiandrosterone sulfate levels on body composition after laparoscopic adjustable gastric banding in pre-menopausal morbidly obese women 185
Polycystic ovary syndrome (PCOS) trilogy: a translational and clinical review 185
Circulating ghrelin concentrations in the polycystic ovary syndrome 184
Prevalence of polycystic ovary morphology in a region of South Italy. 184
Cardiovascular risk of women with polycystic ovary syndrome 184
Efficacy of laparoscopic ovarian diathermy in clomiphene citrate-resistant women with polycystic ovary syndrome: relationships with chronological and ovarian age 183
Antisperm antibodies in cryptorchidism before and after surgery. 183
Pregnancy in women with polycystic ovary syndrome: the effect of different phenotypes and features on obstetric and neonatal outcomes. 182
GH and IGF-I deficiency are associated with reduced loss of fat mass after laparoscopic-adjustable silicone gastric banding. 182
Is plasminogen activator inhibitor-1 a cardiovascular risk factor in young women with polycystic ovary syndrome? 182
Leuprolide acetate treatment with and without coadministration of tibolone in premenopausal women with menstrual cycle-related irritable bowel syndrome 182
Clinical use of the perifollicular vascularity assessment in IVF cycles: a pilot study 182
Evidence for altered adipocyte function in polycystic ovary syndrome. 181
Relationship between growth hormone/insulin-like growth factor-1 axis integrity and voluntary weight loss after gastric banding surgery for severe obesity. 181
Growth hormone treatment prevents loss of lean mass after bariatric surgery in morbidly obese patients: results of a pilot, open, prospective, randomized, controlled study 180
Anti-proliferative and pro-apoptotic effects of raloxifene on uterine leiomyomas in postmenopausal women 180
Clomiphene citrate, metformin or both as first-step approach in treating anovulatory infertility in patients with polycystic ovary syndrome (PCOS): a systematic review of head-to-head randomized controlled studies and meta-analysis 180
Lymphocyte subset pattern in acromegaly. 180
Efficacy of risedronate administration in osteoporotic postmenopausal women affected by inflammatory bowel disease 179
Metformin administration versus laparoscopic ovarian diathermy in clomiphene citrate-resistant women with polycystic ovary syndrome:A Prospective Parallel Randomized Double-Blind Placebo-Controlled Trial 178
Inflammatory markers and visceral fat are inversely associated with maximal oxygen consumption in women with polycystic ovary syndrome (PCOS) 177
Clomiphene citrate versus metformin as first-line approach for the treatment of anovulation in infertile patients with polycystic ovary syndrome 176
Polycystic ovary syndrome: an example of obesity-related cardiovascular complication affecting young women 176
Pervasive developmental disorders in children of hyperandrogenic women with polycystic ovary syndrome: a longitudinal case-control study. 175
Totale 20.394
Salva come PNG Salva come JPEG
Categoria #
all - tutte 166.126
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 166.126
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.800 0 0 0 0 0 0 0 0 0 0 0 1.800
2021/20222.163 139 314 34 771 76 45 253 199 141 116 69 6
2022/20234.290 523 136 215 458 498 796 115 566 571 120 223 69
2023/20241.231 134 71 77 54 54 34 25 316 268 56 12 130
2024/20255.948 86 505 15 133 86 499 1.693 2.000 322 199 205 205
2025/20266.412 491 820 523 413 413 163 988 645 948 710 173 125
Totale 42.220